I second this! CBIS has such a huge advantage over the other players. Plus there really aren't any other players with CBIS' profile of R&D of cannabinoids and patient treatment, most of the other pot players at this point are pushing various products or technologies for growers and users.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.